- Osteonecrosis of the jaw in the era of targeted therapy and immunotherapy in oncology
-
Nifosì AF, Zuccarello M, Nifosì L, Hervas Saus V, Nifosì G
- KMID: 2461485
- J Korean Assoc Oral Maxillofac Surg.
- 2019 Feb;45(1):3-8.
- doi: 10.5125/jkaoms.2019.45.1.3
Osteonecrosis of the jaw (ONJ) is a well-known pathological condition in oncology derived from the use of bisphosphonates (BPs) and denosumab. Many molecular and immunological targets have been introduced for... -
- CITED
-
- Close
- SHARE
-
- Close
